Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 3/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.32 |
| ▸ | FABP3 | P05413 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.30 |
| ▸ | RARG | P13631 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | RXRG | P48443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13988858 | 0.87 | FABP3 (0.40) | THRATHRBACE2FABP3FABP4 | |
| SCHEMBL28218640 | 0.72 | FABP3 (0.41) | THRATHRBACE2FABP3FABP4 | |
| SCHEMBL11928590 | 0.68 | LMNA (0.34) | GABRA1GABRB1 | |
| SCHEMBL11928858 | 0.68 | LMNA (0.34) | GABRA1GABRB1 | |
| SCHEMBL13989036 | 0.67 | GABRA1 (0.38) | THRBGABRA1GABRB1 | |
| SCHEMBL13609861 | 0.66 | LMNA (0.35) | GABRA1GABRB1 | |
| SCHEMBL13988855 | 0.65 | TPMT (0.46) | — | |
| Isopropyl Alcohol SCHEMBL28142316 | 0.65 | GABRA1 (0.59) | THRATHRBFABP3FABP4GABRA1 | |
| SCHEMBL4319072 | 0.64 | GABRA1 (0.63) | THRATHRBFABP3FABP4GABRA1 | |
| SCHEMBL29054130 | 0.63 | FABP3 (0.45) | THRATHRBACE2FABP3FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080306315-A1 | Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation | UNIVERSITETET I OSLO (NO) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080306315-A1 | Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation | POF1B, PMS2, IDH1 | SLC22A8 855/4885SLC22A6 1667/4885THRA 4660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.